Showing results (1581-1590 of 6,884) with videos related to
Sort By:
Pageof 689
Leukemia Research|June 27, 2020
Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemiaFang-Yuan Zheng, Ai-Dong Lu, Ying-Xi Zuo, et al.Leukemia Research|April 18, 2015
The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabineM Lazenby, R Hills, A K Burnett, et al.Leukemia Research|January 1, 1990
Phorbol myristate acetate treatment of normal human myeloid blast cells promotes monopoiesis and inhibits granulopoiesisC M Bunce, W N Patton, J D Pound, et al.Leukemia Research|January 1, 1990
Biochemical basis of the prevention of 6-thiopurine toxicity by the nucleobases, hypoxanthine and adenineH Hashimoto, M Kubota, T Shimizu, et al.Leukemia Research|January 1, 1990
Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methodsN Melo, C Hobday, M Dowsett, et al.Leukemia Research|January 1, 1990
Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: a pilot studyD Macdonald, Y Z Jiang, A A Gordon, et al.Leukemia Research|June 26, 2012
Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomasRan Yu, Gang Chen, Chunju Zhou, et al.Leukemia Research|June 26, 2012
A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapyShabbir M H Alibhai, Sara O'Neill, Karla Fisher-Schlombs, et al.Leukemia Research|June 26, 2012
Mechanism of immunomodulatory drugs in multiple myelomaLenka Sedlarikova, Lenka Kubiczkova, Sabina Sevcikova, et al.Leukemia Research|June 26, 2012
Angiogenic factors in chronic lymphocytic leukemiaYi Xia, Rui-Nan Lu, Jianyong LiPageof 689